School of Medicine Proposal Development Office
The Proposal Development Office (PDO) enables Stanford Medicine faculty to pursue transformative biomedical research. We provide expert consultation on grant proposal strategy, proposal management and facilitation, grant writing and editing, and streamlined proposal administrative support. We also lead initiatives in the School of Medicine that increase institutional competitiveness and enable strategic research growth.
Based in the School of Medicine Research Office, we are uniquely positioned to support teams of Stanford Medicine researchers pursuing interdisciplinary and cross-cutting funding opportunities. Our current priority areas include large, complex, and strategic proposals and early-career faculty research grants.
The PDO has assisted faculty from 27 School of Medicine departments submit more than 242 proposals.
The PDO has supported more than 150 faculty members from across the School of Medicine.
The PDO has helped faculty secure over $613 million in research funding.
The PDO was a fantastic partner at all steps of the proposal development process. The team was highly proactive and skilled. Their advice and support were instrumental in helping us submit a competitive proposal and ultimately receive funding.
Kari Nadeau, MD, PhD, PI of NHLBI P01 "Air pollution disrupts Inflammasome Regulation in HEart And Lung Total Health (AIRHEALTH)"
The PDO team is exceptional. I had no idea what to expect since I had not worked with them previously. They helped me with every aspect of the proposal. Their guidance and advice were invaluable.
Bali Pulendran, PhD, PI of NIAID Human Immunology Project Consortium U19 “Systems biological assessment of innate and adaptive immunity to vaccination”
The PDO team was truly fantastic! They were flexible, dedicated and knowledgeable. The team provided outstanding assistance in integrating and coordinating a complex multi-project application.
Melanie Hayden Gephart, MD, PI of NCI Metastasis Research Network U54 "Deconvolution and interruption of the cancer-neuro-immune axis facilitating brain metastases"